X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs SANOFI INDIA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA SANOFI INDIA FULFORD INDIA/
SANOFI INDIA
 
P/E (TTM) x 398.8 30.0 1,329.5% View Chart
P/BV x 6.2 5.3 117.3% View Chart
Dividend Yield % 0.1 1.7 5.0%  

Financials

 FULFORD INDIA   SANOFI INDIA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
SANOFI INDIA
Dec-16
FULFORD INDIA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs9424,560 20.7%   
Low Rs4504,400 10.2%   
Sales per share (Unadj.) Rs691.41,028.5 67.2%  
Earnings per share (Unadj.) Rs11.5129.0 8.9%  
Cash flow per share (Unadj.) Rs15.4186.0 8.3%  
Dividends per share (Unadj.) Rs2.0068.00 2.9%  
Dividend yield (eoy) %0.31.5 18.9%  
Book value per share (Unadj.) Rs380.0753.6 50.4%  
Shares outstanding (eoy) m3.9023.03 16.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.4 23.1%   
Avg P/E ratio x60.734.7 174.8%  
P/CF ratio (eoy) x45.324.1 188.1%  
Price / Book Value ratio x1.85.9 30.8%  
Dividend payout %17.452.7 33.1%   
Avg Mkt Cap Rs m2,714103,174 2.6%   
No. of employees `0000.43.6 12.3%   
Total wages/salary Rs m5053,592 14.1%   
Avg. sales/employee Rs Th6,073.06,537.7 92.9%   
Avg. wages/employee Rs Th1,137.4991.4 114.7%   
Avg. net profit/employee Rs Th100.7819.8 12.3%   
INCOME DATA
Net Sales Rs m2,69623,686 11.4%  
Other income Rs m125708 17.7%   
Total revenues Rs m2,82224,394 11.6%   
Gross profit Rs m-465,281 -0.9%  
Depreciation Rs m151,313 1.2%   
Interest Rs m1015 63.3%   
Profit before tax Rs m544,661 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,691 0.6%   
Profit after tax Rs m452,970 1.5%  
Gross profit margin %-1.722.3 -7.7%  
Effective tax rate %17.736.3 48.7%   
Net profit margin %1.712.5 13.2%  
BALANCE SHEET DATA
Current assets Rs m1,73815,673 11.1%   
Current liabilities Rs m5456,678 8.2%   
Net working cap to sales %44.338.0 116.6%  
Current ratio x3.22.3 136.0%  
Inventory Days Days4876 63.8%  
Debtors Days Days422 19.3%  
Net fixed assets Rs m128,098 0.1%   
Share capital Rs m39230 16.9%   
"Free" reserves Rs m1,44317,088 8.4%   
Net worth Rs m1,48217,356 8.5%   
Long term debt Rs m00-   
Total assets Rs m2,07725,400 8.2%  
Interest coverage x6.7311.7 2.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.9 139.2%   
Return on assets %2.611.8 22.2%  
Return on equity %3.017.1 17.6%  
Return on capital %4.326.9 16.0%  
Exports to sales %024.5 0.0%   
Imports to sales %24.528.0 87.4%   
Exports (fob) Rs mNA5,801 0.0%   
Imports (cif) Rs m6596,627 9.9%   
Fx inflow Rs m177,145 0.2%   
Fx outflow Rs m6736,846 9.8%   
Net fx Rs m-656299 -219.4%   
CASH FLOW
From Operations Rs m903,226 2.8%  
From Investments Rs m105-1,555 -6.7%  
From Financial Activity Rs m-14-1,818 0.8%  
Net Cashflow Rs m181-147 -122.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 3.8 14.4 26.4%  
FIIs % 0.1 14.6 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.5 201.9%  
Shareholders   4,783 15,184 31.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS